Immunosenescence clinical trials

Explore recruiting immunosenescence clinical trials.

Recruiting immunosenescence studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Immunosenescence trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pan-lesions SBRT combined with lymphocyte support through ATRA-driven blockade of MDSC in patients with oligometastatic solid cancer (LySATRA)

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

The OPTIMIzE study;OPen label multicenter randomized Trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients.

Netherlands, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Immunosenescence trials by city

Immunosenescence in Toronto Immunosenescence in Vancouver Immunosenescence in Montreal Immunosenescence in Calgary Immunosenescence in Edmonton Immunosenescence in Ottawa Immunosenescence in Winnipeg Immunosenescence in Quebec City Immunosenescence in Hamilton Immunosenescence in Kitchener Immunosenescence in London Immunosenescence in Halifax Immunosenescence in New York Immunosenescence in Los Angeles Immunosenescence in Chicago Immunosenescence in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease